NCT03107988 2025-09-15NANT 2015-02: A Phase 1 Study of Lorlatinib (PF-06463922)New Approaches to Neuroblastoma Therapy ConsortiumPhase 1 Completed65 enrolled 38 charts
NCT00075634 2013-09-30Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or NeuroblastomaNational Cancer Institute (NCI)Phase 1 Completed21 enrolled